Nu Skin opened lower at $3.88, compared with its previous close of $3.89. In the last trading session, the stock traded between $3.87 and $4.02. It showed an upward intraday trend.
An investment of $100 made 5 years ago in Nu Skin is now worth
$ 8.94
Resulting in a loss of
$ 91.06 (91.06%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+$0.13 (+3.32%)
Day High
$4.02
Day Low
$3.87
Day Open
$3.88
Prev Close
$3.89
Volume
4,81,159
1W Return
-19.56%
1M Return
-17.54%
3M Return
-17.36%
6M Return
-39.38%
1Y Return
-58.00%
Market Cap ($ Mn)
196
PE Ratio
-
PB Ratio
0.44
PEG Ratio
-
ROE
21.09%
ROCE
18.20%
EPS (TTM)
$-0.02
1 Week
-19.56%
1 Month
-17.54%
3 Months
-17.36%
6 Months
-39.38%
9 Months
-60.48%
Nu Skin Enterprises Q3FY26 Results: Revenue $311M, EPS $0.10
Q3FY26 revenue reached $311 million, within guidance. Adjusted EPS was $0.10, excluding transition costs. Gross margin declined to 65% from 70.5% YoY. FY26 sales guidance held at $1.26B-$1.29B, below analyst estimates. PRISM scan-to-purchase conversion rate doubled to 10%.
7 days agoNu Skin ranked world's No. 1 in beauty devices for third year
Nu Skin ranked world's No. 1 in beauty and wellness device systems by Euromonitor. Ranking marks third consecutive year at top position based on June-July 2026 data. Portfolio includes Prysm iO, ageLOC LumiSpa iO, and RenuSpa iO devices. CEO cites validation of long-term vision for personalized, intelligent wellness.
2mo agoNu Skin Enterprises declares $0.06 quarterly dividend
Nu Skin Enterprises Inc. announced a quarterly cash dividend of $0.06 per share. Payments will be made on Sept. 9, 2026, to shareholders of record on Aug. 28, 2026. The declaration underscores the firm's ongoing commitment to shareholder returns amid its global expansion in beauty and wellness.
3mo agoNu Skin Q2 revenue falls 17%, adjusted EPS meets expectations
Nu Skin Enterprises Inc. posted a 17.1% revenue decline to $320.1 million in Q2 2026, driven by falling customer and affiliate counts. Adjusted EPS of $0.20 met expectations, masking a GAAP loss due to a $78.9 million impairment charge. Management lowered full-year revenue guidance to $1.28-1.35 billion.
3mo agoNu Skin Enterprises Latest Results: GAAP EPS Guidance at $(4.90)-$(4.73)
Nu Skin Enterprises forecasts a FY2026 GAAP EPS loss of $(4.90) to $(4.73), indicating an expected net loss for the fiscal year. The guidance serves as a key indicator of the company's financial trajectory, with no additional revenue or profit metrics provided in the current update.
3mo agoNu Skin Enterprises Q3 Results: Guidance misses estimates
Nu Skin Enterprises reported Q3 guidance missing analyst estimates for both adjusted EPS and sales. EPS is expected at $0.10-$0.20 vs $0.32 est, while sales are guided at $310M-$340M vs $375.5M est, indicating potential operational headwinds.
3mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $167.67 | -0.59% | $3,88,622.68M | 21.72 | |
| $65.78 | -1.04% | $1,61,399.85M | 13.15 | |
| $66.70 | +0.24% | $84,431.39M | 22.93 | |
| $98.00 | -0.09% | $77,902.26M | 35.73 | |
| $108.86 | -1.72% | $66,800.85M | 21.61 | |
| $70.92 | +2.34% | $33,752.18M | 22.34 | |
| $24.27 | +0.12% | $28,731.53M | - | |
| $112.33 | -0.97% | $27,837.96M | 206.78 | |
| $112.02 | +0.23% | $26,440.30M | 32.46 | |
| $176.43 | +1.43% | $25,823.53M | 24.46 | |
| $100.28 | +0.87% | $19,268.20M | 23.00 | |
| $34.21 | -1.13% | $18,291.64M | - |
An investment of $100 made 5 years ago in Nu Skin is now worth
$ 8.94
Resulting in a loss of
$ 91.06 (91.06%)
Note: Past profits do not guarantee future returns.
